Beta-1 vs. beta-2 adrenergic control of coronary blood flow during isometric handgrip exercise in humans.

Abstract

During exercise, β-adrenergic receptors are activated throughout the body. In healthy humans, the net effect of β-adrenergic stimulation is an increase in coronary blood flow. However, the role of vascular β1 vs. β2 receptors in coronary exercise hyperemia is not clear. In this study, we simultaneously measured noninvasive indexes of myocardial oxygen supply (i.e., blood velocity in the left anterior descending coronary artery; Doppler echocardiography) and demand [i.e., rate pressure product (RPP) = heart rate × systolic blood pressure) and tested the hypothesis that β1 blockade with esmolol improves coronary exercise hyperemia compared with nonselective β-blockade with propranolol. Eight healthy young men received intravenous infusions of esmolol, propranolol, and saline on three separate days in a single-blind, randomized, crossover design. During each infusion, subjects performed isometric handgrip exercise until fatigue. Blood pressure, heart rate, and coronary blood velocity (CBV) were measured continuously, and RPP was calculated. Changes in parameters from baseline were compared with paired t-tests. Esmolol (Δ = 3296 ± 1204) and propranolol (Δ = 2997 ± 699) caused similar reductions in peak RPP compared with saline (Δ = 5384 ± 1865). In support of our hypothesis, ΔCBV with esmolol was significantly greater than with propranolol (7.3 ± 2.4 vs. 4.5 ± 1.6 cm/s; P = 0.002). This effect was also evident when normalizing ΔCBV to ΔRPP. In summary, not only does selective β1 blockade reduce myocardial oxygen demand during exercise, but it also unveils β2-receptor-mediated coronary exercise hyperemia.NEW & NOTEWORTHY In this study, we evaluated the role of vascular β1 vs. β2 receptors in coronary exercise hyperemia in a single-blind, randomized, crossover study in healthy men. In response to isometric handgrip exercise, blood flow velocity in the left anterior descending coronary artery was significantly greater with esmolol compared with propranolol. These findings increase our understanding of the individual and combined roles of coronary β1 and β2 adrenergic receptors in humans.

• Authors: Stephan R Maman, Alvaro F Vargas, Tariq Ali Ahmad, Amanda J Miller, Zhaohui Gao, Urs A Leuenberger, David N Proctor, Matthew D Muller
• Journal: Journal of applied physiology (Bethesda, Md. : 1985) (J Appl Physiol (1985)) Vol. 123 Issue 2 Pg. 337-343 (Aug 01 2017) ISSN: 1522-1601 [Electronic] United States
• PMID: 28572492 (Publication Type: Journal Article, Randomized Controlled Trial)
• Copyright: Copyright © 2017 the American Physiological Society.

Chemical References

• Adrenergic Agents
• Receptors, Adrenergic, beta-1
• Receptors, Adrenergic, beta-2
• Propranolol
• Norepinephrine
• Epinephrine

Topics

• Adrenergic Agents (pharmacology)
• Adult
• Blood Flow Velocity (drug effects, physiology)
• Blood Pressure (drug effects, physiology)
• Coronary Circulation (drug effects, physiology)
• Coronary Vessels (drug effects, metabolism, physiopathology)
• Cross-Over Studies
• Epinephrine (pharmacology)
• Exercise (physiology)
• Hand Strength (physiology)
• Heart (drug effects, physiopathology)
• Heart Rate (drug effects, physiology)
• Humans
• Hyperemia (drug therapy, metabolism, physiopathology)
• Male
• Myocardium (metabolism)
• Norepinephrine (pharmacology)
• Propranolol (pharmacology)
• Receptors, Adrenergic, beta-1 (metabolism)
• Receptors, Adrenergic, beta-2 (metabolism)
• Single-Blind Method